Abstract
Gülşah Yamancan, Ahmet Karataş, Damla Arslan, Sümeyye Sahin, Yusuf Dogan, Jehat Kılıç, Burak Öz, Hakan Artas, Süleyman Serdar Koca
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1164/rccm.200706-877oc
10.1164/rccm.200706-877oc
10.1136/ard.2006.066068
10.1136/ard.2006.066068
Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria: systematic review and meta-analysis
10.1016/j.rce.2024.02.002 · 2024
10.1136/annrheumdis-2020-217455
10.1136/annrheumdis-2020-217455
Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease
10.1164/rccm.201903-0563ci · 2020
10.1164/ajrccm/148.4_pt_1.1076
10.1164/ajrccm/148.4_pt_1.1076
10.1148/radiol.2322031223
10.1148/radiol.2322031223
CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review
10.1016/j.crad.2023.11.022 · 2024
High resolution computed tomography in early scleroderma lung disease
1991
10.2214/ajr.169.4.9308447
10.2214/ajr.169.4.9308447
Warrick score in rheumatoid-arthritis interstitial lung disease: a promising tool for assessing the extent and progression of lung involvement
10.1186/s42358-025-00435-w · 2025
Clinical assessment for pulmonary hypertension in interstitial lung disease
10.1111/imj.15887 · 2023
10.1093/rheumatology/kes289
10.1093/rheumatology/kes289
10.1056/nejmoa055120
10.1056/nejmoa055120
10.1056/nejmoa1903076
10.1056/nejmoa1903076
10.1056/nejmoa2503643
10.1056/nejmoa2503643
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
10.1016/s2213-2600(20)30318-0 · 2020
10.1002/art.38098
10.1002/art.38098
10.1148/radiol.2462070712
10.1148/radiol.2462070712
[Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities]
2001
Relation of Warrick score and polysomnographic parameters in patients with interstitial lung disease
10.12659/msm.914905 · 2019
No additional external references are available.